STUDY SEARCH RESULTS

1 study found for your search request:  3475-03B

Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line ...
Condition: Carcinoma, Renal Cell
Minimum Age: 18 years, Maximum Age: 120 years
Gender: All
Study ID: NCT04626518
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site